Foundation Medicine to Launch FoundationOne®PGx, a Pharmacogenetic Offering, Through Expanded Partnership with Fulgent Genetics

AI Briefing

• – Foundation Medicine to Launch FoundationOnePGx, a Pharmacogenetic Offering, Through Expanded Partnership with Fulgent Genetics
• – FoundationOnePGx helps guide cancer therapy selection and dosing strategies to support safer, more effective patient care
• – the expanded partnership with Fulgent Genetics will further enhance Foundation Medicine's ability to provide comprehensive genomic profiling solutions